Chimerix (CMRX) Forms $4.34 Double Bottom; Arlington Asset Investment (FBR) Sentiment Is 1.19

November 15, 2017 - By Winifred Garcia

Chimerix Inc (CMRX) formed double bottom with $4.08 target or 6.00% below today’s $4.34 share price. Chimerix Inc (CMRX) has $204.77 million valuation. The stock decreased 0.46% or $0.02 on November 14, reaching $4.34. About shares traded. Chimerix Inc (NASDAQ:CMRX) has risen 3.54% since November 15, 2016 and is uptrending. It has underperformed by 13.16% the S&P500.

Fibria Celulose S.A. is a forestry company, which is engaged in the production of eucalyptus pulp. The company has market cap of $8.46 billion. The Firm is engaged in the production and sale of short fiber pulp from its pulp production facilities located in the cities of Aracruz (State of Espirito Santo), Tres Lagoas (State of Mato Grosso do Sul), Jacarei (State of Sao Paulo) and Eunapolis (State of Bahia). It has a 38.94 P/E ratio. The Company’s activities are focused on the growth of renewable and forests, and the manufacture and sale of bleached eucalyptus kraft pulp.

Analysts await Chimerix Inc (NASDAQ:CMRX) to report earnings on March, 1. They expect $-0.49 EPS, down 53.13% or $0.17 from last year’s $-0.32 per share. After $-0.37 actual EPS reported by Chimerix Inc for the previous quarter, Wall Street now forecasts 32.43% negative EPS growth.

Among 8 analysts covering Chimerix Inc (NASDAQ:CMRX), 2 have Buy rating, 1 Sell and 5 Hold. Therefore 25% are positive. Chimerix Inc had 17 analyst reports since August 5, 2015 according to SRatingsIntel. The rating was initiated by FBR Capital on Tuesday, August 18 with “Outperform”. As per Monday, December 28, the company rating was downgraded by FBR Capital. As per Thursday, September 3, the company rating was initiated by Citigroup. Morgan Stanley downgraded the shares of CMRX in report on Tuesday, February 23 to “Underweight” rating. Morgan Stanley downgraded Chimerix Inc (NASDAQ:CMRX) rating on Monday, October 5. Morgan Stanley has “Equal-Weight” rating and $50 target. The company was downgraded on Tuesday, February 23 by Barclays Capital. The rating was maintained by Barclays Capital on Tuesday, December 29 with “Overweight”. Brean Capital maintained the stock with “Buy” rating in Thursday, August 6 report. The rating was downgraded by JP Morgan to “Neutral” on Tuesday, December 29. The rating was maintained by Cowen & Co on Monday, August 7 with “Hold”.

Investors sentiment decreased to 0.84 in 2017 Q2. Its down 0.31, from 1.15 in 2017Q1. It is negative, as 13 investors sold Chimerix Inc shares while 31 reduced holdings. 10 funds opened positions while 27 raised stakes. 32.45 million shares or 2.54% more from 31.65 million shares in 2017Q1 were reported. Wells Fargo & Mn accumulated 50,107 shares. Fmr Ltd Limited Liability Company invested 0% in Chimerix Inc (NASDAQ:CMRX). Great West Life Assurance Can reported 4,500 shares stake. 174 are owned by Royal Bancorporation Of Canada. Excalibur Management Corporation invested in 14,400 shares or 0.07% of the stock. Renaissance Tech Limited invested 0% of its portfolio in Chimerix Inc (NASDAQ:CMRX). Meeder Asset reported 0% of its portfolio in Chimerix Inc (NASDAQ:CMRX). Moreover, Invesco has 0% invested in Chimerix Inc (NASDAQ:CMRX) for 111,115 shares. Tudor Inv Corp Et Al stated it has 36,640 shares. The Maryland-based Sandy Spring Bancorporation has invested 0% in Chimerix Inc (NASDAQ:CMRX). Zurcher Kantonalbank (Zurich Cantonalbank) owns 896 shares for 0% of their portfolio. State Common Retirement Fund holds 36,400 shares or 0% of its portfolio. Prescott Gru Capital Mngmt Limited Liability Corp reported 0.35% stake. Gsa Cap Prns Ltd Liability Partnership accumulated 53,867 shares. Jacobs Levy Equity holds 0.01% or 65,580 shares in its portfolio.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Twitter Auto Publish Powered By : XYZScripts.com